LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕
    13/12/2022
    13/12/2022

    EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor

    European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
    Do you like it?
    Read more
    19/09/2022
    19/09/2022

    Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.

    Do you like it?
    Read more
    07/09/2022
    07/09/2022

    Advanced therapy medicinal products: SMEs call for a better investment environment in Europe

    Do you like it?
    Read more
    16/04/2021
    16/04/2021

    Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU

    Webinar Report.
    Do you like it?
    Read more
    05/03/2021
    05/03/2021

    Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

    Webinar Report.
    Do you like it?
    Read more
    12/02/2021
    12/02/2021

    EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion

    On February 4th, Alexion continued its RareConversations event series in cooperation with EuropaBio.
    Do you like it?
    Read more
    02/02/2021
    02/02/2021

    Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

    The purpose of this study is to estimate the economic impact of the production activities of European enterprises applying biotechnology in their research and manufacturing processes.
    Do you like it?
    Read more
    12/02/2020
    12/02/2020

    Industrial biotechnology solutions for sustainable agriculture

    Read our new report on industrial biotech solutions that support the objectives of the CAP revision programme.
    Do you like it?
    Read more
    10/10/2019
    10/10/2019

    EuropaBio Patients BioForum – Key Messages

    Read the key recommendations of the EuropaBio Patients BioForum to the new EU institutions.
    Do you like it?
    Read more
    03/06/2019
    03/06/2019

    Vision for a Circular Bio-Society

    BIC and fifteen organisations set out joint Vision for Europe’s bioeconomy future – a circular bio-society.
    Do you like it?
    Read more
    28/10/2017
    28/10/2017

    From Patent to Patient – The importance of IP rewards and incentives

    The system of IP rewards and incentives exists and works together to allow adequate time for the companies and investors to recoup their years of investment and fully realise clinical value before their inventions become part of the public domain and can be used by others.
    Do you like it?
    Read more
    02/02/2017
    02/02/2017

    “Buying Innovative” in the Healthcare Biotech Market in Europe

    This paper proposes key steps to consider when purchasing biological medicines, looking at each stage of the procurement process.
    Do you like it?
    Read more
    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.